60 Degrees Pharmaceuticals, Inc. (SXTP)

60 Degrees Pharmaceuticals will go public soon. The estimated IPO date is June 1, 2023.
IPO Price Range
$4.30 - $6.30
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading on Jun 1, 2023.
Market Cap 29.52M
Revenue (ttm) 845,174
Net Income (ttm) -5.62M
Shares Out 5.57M
EPS (ttm) -1.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About SXTP

60 Degrees Pharmaceuticals is a growth-oriented specialty pharmaceutical company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. We have successfully achieved regulatory approval of Arakoda, a malaria preventative treatment that has been on the market since late 2019. Currently, 60P’s pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda ... [Read more]

Sector Healthcare
IPO Date Jun 1, 2023
Employees 2
Stock Exchange NASDAQ
Ticker Symbol SXTP
Full Company Profile

Financial Performance

Financial Statements


60 Degrees Pharmaceuticals IPO Registration Document (S-1)

60 Degrees Pharmaceuticals has filed to go public with an IPO on the NASDAQ.

4 months ago - SEC